Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Giacobini

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Alzheimer Disease and Associated Disorders|June 13, 2000
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer diseaseE Giacobini
Progress in Brain Research|January 1, 1996
New trends in cholinergic therapy for Alzheimer disease: nicotinic agonists or cholinesterase inhibitors?E Giacobini
Advances in Biochemical Psychopharmacology|January 1, 1976
Piperidine: a new neuromodulator or a hypogenic substance?E Giacobini
Journal of Physiology, Paris|October 28, 1998
Cholinergic foundations of Alzheimer's disease therapyE Giacobini
The Keio Journal of Medicine|October 1, 1987
Modulation of brain acetylcholine levels with cholinesterase inhibitors as a treatment of Alzheimer diseaseE Giacobini
Journal of Neural Transmission. Supplementum|August 29, 2000
Present and future of Alzheimer therapyE Giacobini
Drugs & Aging|December 31, 1997
Metrifonate. A viewpointE Giacobini
Clinical Neuropharmacology|January 1, 1992
Pharmacological replacement of cholinergic function in Alzheimer diseaseE Giacobini
Advances in Biochemical Psychopharmacology|January 1, 1976
New first messengers in a pluralistic society of neurotransmittersE Giacobini
Current Topics in Developmental Biology|January 1, 1987
Carbonic anhydrase: the first marker of glial developmentE Giacobini
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Alzheimer Disease and Associated Disorders|June 13, 2000
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer diseaseE Giacobini
Progress in Brain Research|January 1, 1996
New trends in cholinergic therapy for Alzheimer disease: nicotinic agonists or cholinesterase inhibitors?E Giacobini
Advances in Biochemical Psychopharmacology|January 1, 1976
Piperidine: a new neuromodulator or a hypogenic substance?E Giacobini
Journal of Physiology, Paris|October 28, 1998
Cholinergic foundations of Alzheimer's disease therapyE Giacobini
The Keio Journal of Medicine|October 1, 1987
Modulation of brain acetylcholine levels with cholinesterase inhibitors as a treatment of Alzheimer diseaseE Giacobini
Journal of Neural Transmission. Supplementum|August 29, 2000
Present and future of Alzheimer therapyE Giacobini
Drugs & Aging|December 31, 1997
Metrifonate. A viewpointE Giacobini
Clinical Neuropharmacology|January 1, 1992
Pharmacological replacement of cholinergic function in Alzheimer diseaseE Giacobini
Advances in Biochemical Psychopharmacology|January 1, 1976
New first messengers in a pluralistic society of neurotransmittersE Giacobini
Current Topics in Developmental Biology|January 1, 1987
Carbonic anhydrase: the first marker of glial developmentE Giacobini
Pageof 18